COMP <GO>
BKV vs CVX // EV/EBITDA & P/E VALUATION
BKV Corporation (NYSE) VS. Chevron Corporation (NYSE) • 15-METRIC TALLY: BKV 6
— CVX 5
▲ EV/EBITDA & P/E VALUATION LEADER: BKV
LAST: $20.94 (-1.09%) • MKT CAP: $2.29B
valuation
5.3x
LAST: $231.46 (+0.99%) • MKT CAP: $457.31B
valuation
21.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BKV VS. CVX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BKV | CVX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 41.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.00% | 5.80% | +3.20 | BKV | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 5.3x | 21.5x | -16.20 | BKV | /valuation <GO> |
| Free Cash Flow Yield | -1.08% | 5.61% | -6.69 | CVX | /fcf-yield <GO> |
| Operating Margin | 26.60% | 8.10% | +18.50 | BKV | /operating-margins <GO> |
| Net Profit Margin | 15.70% | 6.70% | +9.00 | BKV | /net-margins <GO> |
| Revenue Growth (YoY) | 41.60% | -4.60% | +46.20 | BKV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.79% | -2.79 | CVX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.37 | 3.71 | -2.34 | CVX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.0 | 64.7 | -25.69 | CVX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.07 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 10.8x | 34.6x | -23.80 | BKV | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.29B | $457.31B | -$455.02B | CVX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BKV REV | CVX REV | BKV GROSS % | CVX GROSS % | BKV FCF | CVX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.14B | $184.43B | — | 41.3% | -$24.7M | $25.64B |
| FY 2024 | $805.7M | $193.41B | — | 38.4% | $10.0M | $22.79B |
| FY 2023 | $1.01B | $196.91B | — | — | $260.3M | $26.75B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BKV // BETA —
CVX // BETA 1.07